摘要
目的探讨白内障行晶状体超声乳化术后高眼压发生的原因并对不同的处理方法进行分析总结。方法回顾我院2003年1月～2007年12月单纯行晶状体超声乳化并人工晶状体植入术1094例(1482眼),对术后早期发生一过性高眼压眼按发生原因进行分类,并分析药物治疗和前房放液的效果和优缺点。结果本组病例术后发生一过性高眼压共39眼,发生率为2.63%。术后高眼压幅度为21～60mmHg,主要发生在术后有黏弹剂残留和术后炎症反应较重眼。前房放液组中22眼经1次前房放液后眼压维持正常(78.57%),术后1d28眼眼压均控制正常。药物治疗组11眼经治疗后眼压逐渐下降,术后3h眼压全部恢复正常。结论黏弹剂残留和炎症反应是引起晶状体超声乳化术后短暂眼压升高的主要原因,辅助切口放液是一种较为简单、安全、有效的治疗方法。
Objective To probe into the reasons of postoperative high intraoeular pressure following phaeoemulsification and analyze to different treatment methods that summarizes. Methods 1094 eases （ 1482 eyes） who had undergone phaeoemulsification and intraoeular lens implantations in our hospital from January of 2003 to December of 21）07 were observed. The eyes following high intraocular pressure in early days were classified according to different reasons atnd divided into a medication group and decompression of anterior chamber group according to the treatment method. Restilts 39 eyes in our eases took place the high intraoeular pressure in early days after operations, incidence was 2.63%. The range of high intraoeular pressure was 21 - 60 mmHg （ 1 mmHg = 0. 133 kPa）. All of eyes with high intraocular pressure presented residual viscoelastic substance and postoperative severe reaction in anterior chamber. In decompression of anterior chamber group, the intraocular pressure was controlled at normal level by one time decompressing procesure in 22 eyes （78.57%） and in one postoperative day in all of 28 eyes. In medication group, intraocular pressure in 11 eyes dropped gradually and returned to normal in postoperative 3 days. Conclusion Residual viscoelastic substance and postoperative severe reaction in anterior chamber were responsible for causing postoperative transient intraocular pressure elevated following phaeoemulsification. It is a simple, safe, effective therapeutic method to decompress anterior chamber by aside incision.
出处
《眼外伤职业眼病杂志》
2009年第7期499-501,共3页
Journal of Injuries and Occupational Diseases of the Eye with Ophthalmic Surgeries
关键词
白内障
晶状体超声乳化术
眼压
治疗
cataract
phaeoemulsification
intraocular pressure
management
